3-methylhistidine has been researched along with HIV Wasting Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cabahug, CJ; DeCristofaro, KA; Frost, RA; Fuhrer, J; Garlick, PJ; Gelato, MC; Johnson, RW; Lang, CH; McNurlan, MA; Santasier, AM; Steigbigel, RT | 1 |
1 trial(s) available for 3-methylhistidine and HIV Wasting Syndrome
Article | Year |
---|---|
Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease.
Topics: Adult; Basal Metabolism; Disease Progression; Drug Resistance; Female; HIV Wasting Syndrome; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Methylhistidines; Muscle Contraction; Muscle Proteins; Muscle, Skeletal; Myofibrils; Tumor Necrosis Factor-alpha; Viral Load; Weight Gain | 1997 |